Bio-Techne (TECH) Total Debt (2014 - 2026)
Bio-Techne's quarterly Total Debt came in at $200.0 million in Q1 2026, down 39.39% year-on-year from $330.0 million in Q1 2025, and down 23.08% quarter-over-quarter from $260.0 million in Q4 2025.
Bio-Techne has reported Total Debt for 13 years, with the latest figure at $200.0 million in Q1 2026.
- For the quarter ending Q1 2026, Total Debt fell 39.39% year-over-year to $200.0 million; the trailing twelve-month figure through Mar 2026 stood at $200.0 million (down 39.39% YoY), and the FY2025 full-year result was $346.0 million, up 8.46% from the prior year.
- Total Debt for Q1 2026 stood at $200.0 million, down from $260.0 million in the prior quarter.
- The five-year high for Total Debt was $447.0 million in Q4 2023, with the low at $200.0 million in Q4 2022.
- Average Total Debt over 5 years is $314.6 million, with a median of $300.0 million recorded in 2024.
- Year-over-year, Total Debt jumped 123.5% in 2023 and sank 39.39% in 2026.
- Tracing TECH's Total Debt over 5 years: stood at $200.0 million in 2022, then soared by 123.5% to $447.0 million in 2023, then slumped by 32.89% to $300.0 million in 2024, then retreated by 13.33% to $260.0 million in 2025, then slipped by 23.08% to $200.0 million in 2026.
- The last three Total Debt figures came in at $200.0 million (Q1 2026), $260.0 million (Q4 2025), and $300.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 319.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.99 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 200.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200.00 Mn |
| Dec 31, 2025 | 260.00 Mn |
| Sep 30, 2025 | 300.00 Mn |
| Jun 30, 2025 | 346.00 Mn |
| Mar 31, 2025 | 330.00 Mn |
| Dec 31, 2024 | 300.00 Mn |
| Sep 30, 2024 | 300.00 Mn |
| Jun 30, 2024 | 319.00 Mn |
| Mar 31, 2024 | 389.00 Mn |
| Dec 31, 2023 | 447.00 Mn |
| Sep 30, 2023 | 441.75 Mn |
| Jun 30, 2023 | 353.50 Mn |
| Mar 31, 2023 | 375.25 Mn |
| Dec 31, 2022 | 200.00 Mn |
| Sep 30, 2022 | 272.06 Mn |
| Jun 30, 2022 | 255.91 Mn |
| Mar 31, 2022 | 259.01 Mn |
| Dec 31, 2021 | 271.62 Mn |
| Sep 30, 2021 | 292.72 Mn |
| Jun 30, 2021 | 341.33 Mn |
| Mar 31, 2021 | 208.00 Mn |
| Dec 31, 2020 | 224.02 Mn |
| Sep 30, 2020 | 316.93 Mn |
| Jun 30, 2020 | 356.74 Mn |
| Mar 31, 2020 | 413.50 Mn |
| Dec 31, 2019 | 382.95 Mn |
| Sep 30, 2019 | 486.06 Mn |
| Jun 30, 2019 | 505.16 Mn |
| Mar 31, 2019 | 522.27 Mn |
| Dec 31, 2018 | 545.37 Mn |
| Sep 30, 2018 | 561.47 Mn |
| Jun 30, 2018 | 339.00 Mn |
| Mar 31, 2018 | 396.00 Mn |
| Dec 31, 2017 | 415.80 Mn |
| Sep 30, 2017 | 378.40 Mn |
| Jun 30, 2017 | 408.87 Mn |
| Mar 31, 2017 | 410.92 Mn |
| Dec 31, 2016 | 407.16 Mn |
| Sep 30, 2016 | 393.40 Mn |
| Jun 30, 2016 | 91.50 Mn |
| Mar 31, 2016 | 157.81 Mn |
| Dec 31, 2015 | 162.79 Mn |
| Sep 30, 2015 | 164.37 Mn |
| Jun 30, 2015 | 73.00 Mn |
| Mar 31, 2015 | 8.01 Mn |
| Dec 31, 2014 | 144.00 Mn |
| Sep 30, 2014 | 112.00 Mn |
| Jun 30, 2014 | 7.00 Mn |